Jin Medical International (ZJYL) Notes Payables (2023 - 2025)
Jin Medical International (ZJYL) has disclosed Notes Payables for 3 consecutive years, with $18.8 million as the latest value for Q3 2025.
- Quarterly Notes Payables rose 66.37% to $18.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $18.8 million through Sep 2025, up 66.37% year-over-year, with the annual reading at $18.8 million for FY2025, 66.37% up from the prior year.
- Notes Payables hit $18.8 million in Q3 2025 for Jin Medical International, up from $11.3 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $18.8 million in Q3 2025 to a low of $4.1 million in Q3 2023.
- Historically, Notes Payables has averaged $11.4 million across 3 years, with a median of $11.3 million in 2024.
- Biggest five-year swings in Notes Payables: skyrocketed 175.28% in 2024 and later surged 66.37% in 2025.
- Year by year, Notes Payables stood at $4.1 million in 2023, then skyrocketed by 175.28% to $11.3 million in 2024, then soared by 66.37% to $18.8 million in 2025.
- Business Quant data shows Notes Payables for ZJYL at $18.8 million in Q3 2025, $11.3 million in Q3 2024, and $4.1 million in Q3 2023.